AKT1 and prostate carcinoma: AKT can control FOXM1 expression in osteosarcoma [21], and the downregulation of AKT by siRNA has been shown to inhibit FOXM1 expression; whereas the overexpression of AKT increased FOXM1 expression in prostate cancer [15].